A detailed history of Mill Creek Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mill Creek Capital Advisors, LLC holds 2,993 shares of GILD stock, worth $247,880. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,993
Holding current value
$247,880
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $189,007 - $218,129
2,993 New
2,993 $205,000
Q4 2023

Feb 14, 2024

BUY
$73.27 - $83.09 $56,198 - $63,730
767 Added 26.46%
3,666 $296,000
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $39,705 - $43,319
-537 Reduced 15.63%
2,899 $217,000
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $52,902 - $60,343
696 Added 25.4%
3,436 $264,000
Q1 2023

May 15, 2023

SELL
$77.31 - $88.08 $1.45 Million - $1.65 Million
-18,747 Reduced 87.25%
2,740 $227,000
Q4 2022

May 25, 2023

BUY
$62.32 - $89.47 $997 - $1,431
16 Added 0.58%
2,756 $237 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $1.34 Million - $1.92 Million
21,487 New
21,487 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $104B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mill Creek Capital Advisors, LLC Portfolio

Follow Mill Creek Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mill Creek Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mill Creek Capital Advisors, LLC with notifications on news.